Starkey today announced that Omega AI+ has been named a CES 2027 Innovation Awards<sup>®</sup> Honoree in the Accessibility & Longevity category. The recognition honors outstanding design and engineering in consumer technology and highlights Starkey’s commitment to advancing hearing innovation that delivers meaningful benefits for individuals with hearing loss and the professionals who care for them....
Continue reading at Hearing Tracker
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable clinical change — a consumer technology award reflects design recognition, not clinical efficacy evidence.
Major industry award recognition for an AI-powered hearing device signals growing mainstream consumer-tech attention to hearing accessibility, which may shape patient expectations in the clinic.
- 01Starkey's Omega AI+ named a CES 2027 Innovation Awards Honoree in Accessibility & Longevity category.
- 02Award is based on design and engineering merit, not clinical performance data.
- 03Recognition comes from CES, a major consumer electronics trade show, not an audiology body.
- 04No clinical trial or outcome data accompanies this announcement.
- 05May increase patient inquiries about AI-featured hearing devices.
The Omega AI+ represents a breakthrough in hearing innovation as recognized by the CES 2027 Innovation Awards.
press releasepromotional